Silence Therapeutics plc Cash Flows From Used In Financing Activities
Silence Therapeutics plc (SLNCF) reported Cash Flows From Used In Financing Activities of GBP 25.16 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2024-03-13
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2023-12-31 | 25.16M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 43.05M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 30.71M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 15.43M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 5.27M GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | 341.00K GBP 20-F/A · filed 2021-04-29 |